82 related articles for article (PubMed ID: 538672)
21. Nephrotic syndrome: increased platelet prostaglandin endoperoxide formation, hyperaggregability, and reduced platelet life span. Reversal following remission.
Stuart MJ; Spitzer RE; Nelson DA; Sills RH
Pediatr Res; 1980 Sep; 14(9):1078-81. PubMed ID: 7454449
[No Abstract] [Full Text] [Related]
22. Studies on the biological balance between thromboxanes and prostacyclins in relation to the platelet-vessel wall interaction.
Jørgensen KA
Dan Med Bull; 1982 May; 29(4):169-97. PubMed ID: 6286257
[No Abstract] [Full Text] [Related]
23. [Platelet aggregation and calcium: Feedback inhibition and intracellular calcium ions].
Kimura Y
Rinsho Byori; 1979; Suppl 40():83-8. PubMed ID: 551230
[No Abstract] [Full Text] [Related]
24. Low density lipoprotein (LDL) from male volunteers stimulated the thromboxane formation by human platelets.
Beitz J; Panse M; Förster W
Prostaglandins Leukot Med; 1983 Apr; 10(4):443-8. PubMed ID: 6574527
[TBL] [Abstract][Full Text] [Related]
25. Non-steroidal anti-inflammatory drugs and platelet function.
McQueen EG; Facoory B; Faed JM
N Z Med J; 1986 May; 99(802):358-60. PubMed ID: 3464876
[TBL] [Abstract][Full Text] [Related]
26. [Determination of malondialdehyde (MDA) formation in thrombocytes].
Stepanauskas M; Norden C; Heine H; Staak R
Z Med Lab Diagn; 1982; 23(6):332-8. PubMed ID: 7170826
[No Abstract] [Full Text] [Related]
27. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
Mazurov AB; Leĭtin VL; Repin VS
Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
[TBL] [Abstract][Full Text] [Related]
28. Malondialdehyde production and the release reaction in rat blood platelets: inhibition by aspirin and indomethacin ex vivo [proceedings].
Gordon JL; MacIntyre DE; McMillan RM
Br J Pharmacol; 1976 Oct; 58(2):299P-300P. PubMed ID: 974415
[No Abstract] [Full Text] [Related]
29. Platelet activity in mitral valve prolapse: a study of platelet aggregation, malondialdehyde production, and plasma beta-thromboglobulin.
Arocha F; Diez-Ewald M; Durango AI; Sulbarán T
Am J Hematol; 1985 May; 19(1):21-5. PubMed ID: 2580431
[TBL] [Abstract][Full Text] [Related]
30. Sex-related difference in the effect of aspirin on prostaglandin metabolism in rat platelet and aorta.
Morikawa M; Inoue M; Kojima T; Uchiyama K; Tsuboi M
Biochem Biophys Res Commun; 1981 Nov; 103(1):77-81. PubMed ID: 7032525
[No Abstract] [Full Text] [Related]
31. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation.
Tantry US; Bliden KP; Gurbel PA
J Am Coll Cardiol; 2005 Nov; 46(9):1705-9. PubMed ID: 16256872
[TBL] [Abstract][Full Text] [Related]
32. Malonaldehyde formation in intact platelets is catalysed by thromboxane synthase.
McMillan RM; MacIntyre DE; Booth A; Gordon JL
Biochem J; 1978 Nov; 176(2):595-8. PubMed ID: 743261
[TBL] [Abstract][Full Text] [Related]
33. Glutathione peroxidase blockage inhibits prostaglandin biosynthesis in rat platelets and aorta.
Doni MG; Piva E
Haemostasis; 1983; 13(4):240-3. PubMed ID: 6352424
[TBL] [Abstract][Full Text] [Related]
34. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
35. Changes in thrombin-stimulated platelet malondialdehyde production during the menstrual cycle.
Tindall H; Zuzel M; Paton RC; McNicol GP
J Clin Pathol; 1981 Jun; 34(6):595-8. PubMed ID: 7251901
[TBL] [Abstract][Full Text] [Related]
36. Malondialdehyde (MDS) re-appearance in human platelet density subpopulations after a single intake of aspirin.
Boneu B; Sie P; Caranobe C; Nouvel C; Bierme R
Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):609-20. PubMed ID: 7444865
[No Abstract] [Full Text] [Related]
37. Comparison of the malondialdehyde formation in megakaryocytes and platelets after in vivo and in vitro administration of aspirin.
Saigo K; Ryo R; Nakaya Y; Yamaguchi N
Nihon Ketsueki Gakkai Zasshi; 1987 Feb; 50(1):138-47. PubMed ID: 3109189
[No Abstract] [Full Text] [Related]
38. The effect of halofenate--free acid on aggregation--the release reaction, coagulant activity, and lipid metabolism of human platelets.
Huzoor-Akbar ; Ardlie NG
Thromb Haemost; 1977 Oct; 38(3):612-9. PubMed ID: 579507
[TBL] [Abstract][Full Text] [Related]
39. Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin.
Falcinelli E; Giannini S; Boschetti E; Gresele P
Br J Haematol; 2007 Jul; 138(2):221-30. PubMed ID: 17593030
[TBL] [Abstract][Full Text] [Related]
40. Malondialdehyde formation in rat platelet-rich plasma. II. Modification of the reaction kinetics by aspirin and indomethacin in vitro.
Livio M; Rajtar G; Merino J; de Gaetano G
Thromb Haemost; 1980 Oct; 44(2):52-5. PubMed ID: 7455991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
